Skip to main navigation
  • Skip to main content
  • Skip to footer
Scholar Rock

Scholar Rock - Utility Menu

  • Careers
  • Contact Us

Main navigation

  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Learn About Our Company
  • Our Science
    • Structural Insights & the Growth Factor Precursor
    • Platform
    • Publications & Posters
    • Learn About Our Science
  • Our Pipeline
    • Spinal Muscular Atrophy
    • Oncology
    • Fibrosis
    • Iron-Restricted Anemia
    • Clinical Trials
    • Learn About Our Pipeline
  • Patients & Families
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Management Team
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR

Breadcrumb

Home / Investors & Media / Corporate Governance / Management Team / Ted Myles

Ted Myles

Explore Investors & Media

  • Investor Overview
  • Press Releases
    • Archived Press Releases
  • Events & Presentations
  • Corporate Governance
    • Committee Composition
    • Management Team
    • Board of Directors
  • Financials & Filings
    • SEC Filings
  • Stock Information
    • Historical Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact IR
Ted Myles has served as Chief Financial Officer & Head of Business Operations since July 2020. Prior to joining our executive team, Mr. Myles served as a member of our board of directors from November 2018 until July 2020. Mr. Myles most recently served as Chief Financial Officer and Chief Operating Officer of AMAG Pharmaceuticals, Inc., a commercial-stage bio-pharmaceutical company.  Prior to AMAG, he served as Chief Financial Officer and Chief Operating Officer at Ocata Therapeutics, Inc. (acquired by Astellas), Chief Financial Officer and Vice President of Operations at PrimeraDx, Inc. (acquired by Qiagen), and Controller of EMD Pharmaceuticals (now EMD Serono, a part of Merck KGaA). Earlier in his career, Mr. Myles was an associate in the healthcare investment banking group at SG Cowen Securities Corporation and was a senior associate in the audit practice of Coopers & Lybrand LLP. Mr. Myles holds a Master of Business Administration from John M. Olin School of Business at Washington University and Bachelor of Science in Business Administration from the University of Hartford.
Myles
Ted Myles
CFO & Head of Business Operations
    Return to Management Team Page
    Meet our Board of Directors
    • RSS Feeds
    • Search

    Footer

    SCHOLAR ROCK
    620 Memorial Dr 2nd Floor
    Cambridge, MA 02139

    MOVING EARLY 2021 TO
    301 Binney Street, 3rd Floor
    Cambridge, MA 02142

    Phone: 857.259.3860
    info@scholarrock.com

    Contact Us

    LinkedIn Twitter

    Scholar Rock - Main navigation

    • Our Company
      • Management Team
      • Board of Directors
      • Partnering
      • Learn About Our Company
    • Our Science
      • Structural Insights & the Growth Factor Precursor
      • Platform
      • Publications & Posters
      • Learn About Our Science
    • Our Pipeline
      • Spinal Muscular Atrophy
      • Oncology
      • Fibrosis
      • Iron-Restricted Anemia
      • Clinical Trials
      • Learn About Our Pipeline
    • Patients & Families
    • Investors & Media
      • Press Releases
        • Archived Press Releases
      • Events & Presentations
      • Corporate Governance
        • Committee Composition
        • Management Team
        • Board of Directors
      • Financials & Filings
        • SEC Filings
      • Stock Information
        • Historical Stock Lookup
        • Investment Calculator
        • Analyst Coverage
      • Investor FAQs
      • Contact IR
    • Community Guidelines
    • Expanded Access Policy
    • Terms of Use
    • Privacy Policy

    Scholar Rock, Inc. © 2021 All Rights Reserved

      Scholar Rock - Main navigation

    • Our Company
      • Management Team
      • Board of Directors
      • Partnering
      • Learn About Our Company
    • Our Science
      • Structural Insights & the Growth Factor Precursor
      • Platform
      • Publications & Posters
      • Learn About Our Science
    • Our Pipeline
      • Spinal Muscular Atrophy
      • Oncology
      • Fibrosis
      • Iron-Restricted Anemia
      • Clinical Trials
      • Learn About Our Pipeline
    • Patients & Families
    • Investors & Media
      • Press Releases
        • Archived Press Releases
      • Events & Presentations
      • Corporate Governance
        • Committee Composition
        • Management Team
        • Board of Directors
      • Financials & Filings
        • SEC Filings
      • Stock Information
        • Historical Stock Lookup
        • Investment Calculator
        • Analyst Coverage
      • Investor FAQs
      • Contact IR
    • Scholar Rock - Utility Menu

    • Careers
    • Contact Us